Anticoagulation and NOACs Flashcards

(42 cards)

1
Q

PT (INR) measures Extrinsic pathway (FVII and then combined pathway X + V -> II). Causes of prolonged PT?

A
Factor VII deficiency
Warfarin
Oral Xa inhibitors
LAC
Mild factor X, V or II def
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

aPTT measures intrinsic pathway (Factors XII, XI, IX and VIII and then combined X+V and II). Causes of prolonged aPTT?

A

Factors XII, XI, IX and VIII def
vWD
LAC
Mild X, V or II def

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the best predictor of perioperative bleeding?

A

The bleeding history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does Heparin affect the coag assay?

A

Prolong aPPT and TT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What test confirms the presence of Heparin?

A

Reptilase time

Activates prothrombin, not inhibited by heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What prolongs reptilase time?

A

Abnormal or reduced fibrinogen
Hypoalbuminaemia
Raised FDPs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What causes a prolonged PT and APTT?

A

Vit K def
Warfarin anticog
Liver failure
Combined V and VIII def

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What causes a long PT, APTT, TT and normal or abnormal fibrinogen?

A

Heparin in large amounts
Liver disease
Finronogen def or disorder
Excess dabigatran and anticoagulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What causes a long PT, APTT, Normal TT and Normal or abnormal Fibrinogen and low platelet count?

A

Massive transfusion

Liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What causes a long PT, APTT, TT, low fibrinogen and low platelet count?

A

DIC

Acute liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Antithrombin deficiency. What, associations?

A

AD
Prevalence of symptomatic disease 0.01%

Antithrombin inhibits XIIa, Xia, IXa and Xa

Acquired casues are DIC, cirrhosis, nephrotic syndrome and L- asparaginase therapy

Associated with VTE from puberty in 55%
Recurrence of 60%

Very high risk of VTE in pregnancy = 50%
prophylactic anti-coagulation and antithrombin concentrates at delivery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Protein C and S def.

What, prevalence, causes, associations?

A

AD
Prevalence of symptomatic disease is 0.1% or less

Acquired causes are liver disease, warfarin therapy, OCP and preg

Associations:
VTE from puberty, less risk than antithrombin. Spontaneous and associated with surgery, trauma, pregnancy etc.

Warfarin induced skin necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Role of activated protein C?

A

Protein C inactivates Factor V and FVIII with protein S as a cofactor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What inherited clotting disorder is associated with venous, not arterial thrombosis?

A

Activated protein C resistance
- Mutation Factor V Leiden found

Moderate risk for venous thrombosis
Synergictic with OCP, preg, Sx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Elevated Factor VIII.
Cause
Main risk association

A

Elevtaed levels are related to ABO blood group - Group O have lower FVIII
Inherited in some

FVIII levels may rise with infection, inflammation etc
Rise with age, esp post menopause

Elevated FVIII >150% (1.5 IU/L) is associated with a 4.8 fold risk of VTE!!!
Greater than activated protein C resistance (Factor V Leiden) etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pregnancy associated VTE. Highest risk periods?

A

Highest risk post partum, 5 x higher
1st trimester higher risk than others.
Left LL more common = 85%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Coagulation Tx for unprovoked VTE?

A

3 months

With mild RF, 3 months then reassess

18
Q

Coagulation Tx period for Recurrent idiopathic VTE?

A

Long term warfarin

19
Q

First idiopathic VTE. Tx period?

When do you consider long term warfarin?

A
Tx for 3-6 months
Consider long term warfarin id
- life threatening 1st event
- unusual site esp if APLS
- incomplete recovery from primary event
- patient preference
- APLS
- high risk thrombophilia
20
Q

HITTS Mx?

A

Stop heparin
DO NOT GIVE PLATELETS
Start Danaparoid, argatroban or fondaprinux
Delay starting warfarin until platelet count recovers

21
Q

What are the long distance guidelines for VTE prevention in pts with no RF for VTE vs. patients with RF?

A
No RF:
Flight > 6 hrs
- avoid constrictive clothing around lower extrememties or waste
- avoid hydration
- do frequent calf muscle stretching

RF:
Above PLUS
- properly fitted below knee GCS providing 15-30 mmHg of pressure at the ankle (grade 2B) OR
Single dose LMWH injected prior to departure

No evidence for aspirin in VTE prevention associated with travel (grade 1B)

22
Q

Prasugel. MOA. Indications. CI?

A

Reversibly binds to P2Y12 receptor and inhibits platelet aggregation for the life of the platelet.

Indications:
ACS to be managed with PCI (with aspirin)

AE:
Common is bleeding
Rare - angioedema

CI:
Hx of stroke of TIA due to increased risk of bleeding

23
Q

Which factors initiate coagulation?

A

Factor VII and tissue factor (VIIa)

24
Q

Which bleeding disorder can have a severe phenotype but normal APTT and PT?

A

Factor XIII

Factor XIII crosslinks fibrin to stabilise the clot in the last step

25
How is vWBD most commonly inherited? | Which factor is vWB a carrier for?
AD Factor VIII therefore low in vWD and prolonged aPPT
26
The antithrombotic effect of warfarin is due to its inhibition of?
Factor II (Prothrombin) Antithrombotic effect is not present until the 5th day if therapy. Depends on clearance of prothrombin which has a half life of 50 hrs.
27
The anticoagulant activity of warfarin is dependent on?
The clearance of clotting factors from the systemic circulation after the 1st dose. The clearance is determined by the half lives. the changes are noted 24-36 hrs and due to clearance of Factor VII which is the clotting factor with the shortest half life.
28
What does prothrombinex contain?
Inactivated concentrate of II, IX and X with variable amounts of VII Activated prothrombinex used when pt has an inhibitor
29
Actions of antiphospholipid syndrome in vivo (inside living organism) vs. in vitro (test tube)?
In vivo = prothrombotic In vitro = prolong APTT If no AI features = primary APS Tx: Lifelone anticoagulation
30
Protein C activated by?
Thrombin
31
Greater risk of recurrent DVT/PE. Antithrombin III deficiency or Protein C deficiency?
Antithrombin deficiency portends the highest risk of VTE but is not a common genetic thrombophilia
32
What is the most common cause of acquired protein C resistance?
Factor V Leiden
33
What is the difference between Factor V Leiden and Protein C deficiency?
Factor V Leiden is the congenital form of Protein C resistance. Protein C def also affects the same pathway but does not cause resistance of FVL to APC - just less Activated protein C
34
MOA protein C?
Inactivate FVa (cleaves Xa to thrombin) and inactivates VIIIa
35
What is the better Tx for HITS in the prevention of thrombosis? LMWH or Direct thrombin inhibitor?
Direct thrombin inhibitor - danaparoid or fondaparinux. Warfarin can be commenced once the PLTs >= 150, 000/microL
36
How do you monitor Rivaroxiban?
Anti-Xa level specific for rivaroxiban Also anti-Xa levels specific for Apixaban present 30% renal excretion 70% liver (CYP3A4) Half life 9 hrs
37
How do you measure for Dabigatran?
Dilute thrombin clotting time assay (HEMOCLOT assay) Half life of dabigatran is 12-14h
38
MOA of thrombolysis?
Activation of plasminogen
39
What is the most common cause of bud chairi syndrome?
Polycythemia Rubra vera is themsot common cause overall. Myeloproliferative disease cause 50% ``` Other causes: PNH Pregnancy and OCP Drugs- azathioprine, adriamycin Cancer esp HCC, renal Hypercoagulable states e.g. FVL mutations, APLS, ATIII/PC/PS def Idiopathic 20% ```
40
Myeloproliferative disorder BCR-ABL +ve. Dx?
CML
41
Myelopriliferative disorder, BCR-ABL -ve, JAK-2 +ve. Dx?
PRV, > 90% 50% MF and ET
42
Myelopriliferative disorder, BCR-ABL -ve, JAK-2 -ve. Dx?
50% ET and MF Infrequent PRV